These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29253843)

  • 1. ICS Use May Modify FEV1 Decline in α1-Antitrypsin Deficiency Patients with Relatively High Blood Eosinophils.
    Low EV; Hughes SM; Zaffarullah S; Kantas D; Stockley RA; Turner AM
    Respiration; 2018; 95(2):114-121. PubMed ID: 29253843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled corticosteroids, blood eosinophils, and FEV
    Whittaker HR; Müllerova H; Jarvis D; Barnes NC; Jones PW; Compton CH; Kiddle SJ; Quint JK
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1063-1073. PubMed ID: 31213788
    [No Abstract]   [Full Text] [Related]  

  • 3. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
    Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
    Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD.
    Cheng SL; Wang HH; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2231-2238. PubMed ID: 28814851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV
    Fähndrich S; Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R
    Respir Med; 2017 Aug; 129():8-15. PubMed ID: 28732839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
    Cheng SL; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2341-2348. PubMed ID: 27703344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood eosinophils as a marker of response to inhaled corticosteroids in COPD.
    Barnes NC; Sharma R; Lettis S; Calverley PM
    Eur Respir J; 2016 May; 47(5):1374-82. PubMed ID: 26917606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of lung function after lung transplantation for α(1)-antitrypsin deficiency.
    Banga A; Gildea T; Rajeswaran J; Rokadia H; Blackstone EH; Stoller JK
    Am J Respir Crit Care Med; 2014 Aug; 190(3):274-81. PubMed ID: 25003824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD.
    Mathioudakis AG; Bikov A; Foden P; Lahousse L; Brusselle G; Singh D; Vestbo J
    Eur Respir J; 2020 May; 55(5):. PubMed ID: 32108044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal changes in forced expiratory volume in 1 s in patients with eosinophilic chronic obstructive pulmonary disease.
    Jo YS; Moon JY; Park YB; Kim YH; Um SJ; Kim WJ; Yoon HK; Yoo KH; Jung KS; Rhee CK
    BMC Pulm Med; 2022 Mar; 22(1):91. PubMed ID: 35296272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.
    Stoller JK; Aboussouan LS; Kanner RE; Wilson LA; Diaz P; Wise R;
    Ann Am Thorac Soc; 2015 Dec; 12(12):1796-804. PubMed ID: 26653189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive smoking diminishes the differences in quality of life and exacerbation frequency between the alpha-1-antitrypsin deficiency genotypes PiZZ and PiSZ.
    Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R; Fähndrich S
    Respir Med; 2017 Sep; 130():1-8. PubMed ID: 29206626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled corticosteroids and FEV
    Whittaker HR; Jarvis D; Sheikh MR; Kiddle SJ; Quint JK
    Respir Res; 2019 Dec; 20(1):277. PubMed ID: 31801539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
    Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
    COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between COPD exacerbations and lung function decline during maintenance therapy.
    Kerkhof M; Voorham J; Dorinsky P; Cabrera C; Darken P; Kocks JW; Sadatsafavi M; Sin DD; Carter V; Price DB
    Thorax; 2020 Sep; 75(9):744-753. PubMed ID: 32532852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring COPD patients: systemic and bronchial eosinophilic inflammation in a 2-year follow-up.
    Pignatti P; Visca D; Zappa M; Zampogna E; Saderi L; Sotgiu G; Centis R; Migliori GB; Spanevello A
    BMC Pulm Med; 2024 May; 24(1):247. PubMed ID: 38764008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT).
    Esquinas C; Serreri S; Barrecheguren M; Rodriguez E; Nuñez A; Casas-Maldonado F; Blanco I; Pirina P; Lara B; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1001-1007. PubMed ID: 29615836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline in FEV
    Hiller AM; Piitulainen E; Jehpsson L; Tanash H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship of the 2011 Global Initiative for Chronic Obstructive Lung Disease strategy to clinically relevant outcomes in individuals with α1-antitrypsin deficiency.
    Pillai AP; Turner AM; Stockley RA
    Ann Am Thorac Soc; 2014 Jul; 11(6):859-64. PubMed ID: 24950156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.
    Song JH; Lee CH; Kim JW; Lee WY; Jung JY; Park JH; Jung KS; Yoo KH; Park YB; Kim DK
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2455-2464. PubMed ID: 28860740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.